BrainStorm Cell Therapeutics
BCLI
#10410
Rank
NZ$10.64 M
Marketcap
NZ$0.96
Share price
0.00%
Change (1 day)
-63.15%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2025 (TTM): -NZ$19.36 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$20.02 Million, an increase over its 2023 earnings that were of -NZ$29.61 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$19.36 Million-3.3%
2024 -NZ$20.02 Million-32.39%
2023 -NZ$29.61 Million-29.18%
2022 -NZ$41.81 Million-0.74%
2021 -NZ$42.12 Million-23.12%
2020 -NZ$54.78 Million36.8%
2019 -NZ$40.05 Million66.71%
2018 -NZ$24.02 Million181.66%
2017 -NZ$8.53 Million-0.6%
2016 -NZ$8.58 Million-41.31%
2015 -NZ$14.62 Million-8.22%
2014 -NZ$15.93 Million89.74%
2013 -NZ$8.4 Million42.27%
2012 -NZ$5.9 Million-12.45%
2011 -NZ$6.74 Million63.04%
2010 -NZ$4.14 Million35.52%
2009 -NZ$3.05 Million-48.99%
2008 -NZ$5.98 Million-44.39%
2007 -NZ$10.76 Million
2005 -NZ$5.57 Million-91.44%
2004 -NZ$65.06 Million94007.62%
2003 -NZ$0.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
NZ$17.02 B-86,455.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-NZ$1.3 Billion 6,468.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-NZ$1.37 Billion 6,805.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$3.27 B-16,731.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$35.58 M-280.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-NZ$0.44 Billion 2,131.73%๐Ÿ‡บ๐Ÿ‡ธ USA